Related Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Related Disease stocks.

Related Disease Stocks Recent News

Date Stock Title
May 7 NBIX Neurocrine Biosciences to Present at the BofA Securities 2024 Health Care Conference
May 7 NBIX Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst™ Program of Crinecerfont in CAH, and Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH Studies at ECE 2024
May 7 ERNA Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MS...
May 7 ERNA Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on the Development of a mRNA-Engineered iPSC Line which Mimics Native B2M Expression, via Targeted Insertion of HLA-E at the B2M Locus
May 6 REGN Regeneron Announces Investor Conference Presentations
May 6 REGN Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks
May 6 NBIX Neurocrine Biosciences Supports Tardive Dyskinesia Awareness Week by Advocating for Routine Screening and Monitoring
May 5 REGN Wall Street Breakfast: The Week Ahead
May 4 NBIX Nvidia Leads Five Stocks Near Buy Points As Market Rally Picks Up Steam
May 4 REGN 23 Most Profitable Stocks of the Last 12 Months
May 3 NBIX Neurocrine Biosciences Presented CAHtalyst™ Pediatric Study Baseline Characteristics and CAHtalog™ Registry Data at PES 2024
May 3 REGN Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
May 3 REGN Regeneron Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
May 3 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
May 3 REGN Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
May 2 NXTC NextCure GAAP EPS of -$0.61 misses by $0.15
May 2 NXTC NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
May 2 REGN Regeneron Pharmaceuticals, Inc. (REGN) Q1 2024 Earnings Call Transcript
May 2 REGN Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
May 2 REGN Regeneron (REGN) Reports Q1 Earnings: What Key Metrics Have to Say
Related Disease

Browse All Tags